AMEX:SLS - SLS International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$0.0008Today's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesHeadlinesSEC Filings Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SLS international is a language services company which offers translations globally. The Company offers a range of services, including multilingual translations into all Spanish variants, localization, adaptation and content editing. It uses the mother-tongue linguists in order to meet the demanding standards. Its professional team includes translators, terminologists, linguistic engineers, IT experts, technical editors and graphic designers. The Company’s production offices and management departments are located in Argentina, Spain, Uruguay and Panama. The Company offers translations within a range of fields such as legal, financial, business, economy, and health sciences, marketing, advertising and technical. It translates and adapts all of the customer’s software products, such as resource files, online help, printed documentation, including compilation and testing of various components. Receive SLS News and Ratings via Email Sign-up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange AMEX Industry N/A Sub-IndustryN/A SectorN/A Current SymbolAMEX:SLS Previous Symbol CUSIPN/A Webwww.sls-international.com Phone+1-417-8834549Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A OptionableNot Optionable SLS International (AMEX:SLS) Frequently Asked Questions What is SLS International's stock symbol? SLS International trades on the AMEX under the ticker symbol "SLS." How were SLS International's earnings last quarter? SLS International Inc (AMEX:SLS) issued its quarterly earnings data on Thursday, November, 15th. The biotechnology company reported ($0.53) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.17. View SLS International's Earnings History. What price target have analysts set for SLS? 4 brokers have issued twelve-month price objectives for SLS International's shares. Their predictions range from $4.00 to $13.00. On average, they anticipate SLS International's stock price to reach $7.3333 in the next twelve months. View Analyst Price Targets for SLS International. What is the consensus analysts' recommendation for SLS International? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SLS International in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SLS International. What are Wall Street analysts saying about SLS International stock? Here are some recent quotes from research analysts about SLS International stock: 1. According to Zacks Investment Research, "SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States. " (1/16/2019) 2. Maxim Group analysts commented, "Sellas announced final data from the triple negative breast cancer (TNBC) group in the P2b study of nelipepimut-S vaccine (NPS, NeuVax) combined with Herceptin. The data vs. Herceptin alone, continue to demonstrate improved reduction in risk of recurrence or death, and improved disease free survival (DFS), this time at median followup of over 2 years (19 mo at interim in April)." (10/22/2018) Has SLS International been receiving favorable news coverage? Press coverage about SLS stock has been trending somewhat positive this week, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. SLS International earned a daily sentiment score of 1.6 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. Who are SLS International's key executives? SLS International's management team includes the folowing people: Angelos M. Stergiou M.D., President, Chief Executive Officer, DirectorAleksey N. Krylov, Interim Chief Financial Officer, TreasurerNicholas J. Sarlis M.D. Ph.D., Chief Medical Officer, Senior Vice PresidentGregory M. Torre Ph.D. J.D., Chief Regulatory Officer, Senior Vice PresidentJohn Thomas Burns, Vice President - Finance, Corporate ControllerFabio Lopez, DirectorDavid A. Scheinberg, DirectorStephen F. Ghiglieri, Independent Director (Age 55)Robert L. Van Nostrand, Independent DirectorJohn Varian, Independent Director How do I buy shares of SLS International? Shares of SLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is SLS International's official website? The official website for SLS International is http://www.sls-international.com/. How can I contact SLS International? SLS International's mailing address is 3119 S Scenic Ave, SPRINGFIELD, MO 65807-3926, United States. The biotechnology company can be reached via phone at +1-417-8834549 or via email at [email protected] MarketBeat Community Rating for SLS International (AMEX SLS)Community Ranking: 3.5 out of 5 ( )Outperform Votes: 385 (Vote Outperform)Underperform Votes: 165 (Vote Underperform)Total Votes: 550MarketBeat's community ratings are surveys of what our community members think about SLS International and other stocks. Vote "Outperform" if you believe SLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2019 by MarketBeat.com StaffFeatured Article: What does the Dow Jones Industrial Average (DJIA) measure?